← Back to headlines
NTHI's Nasdaq Advantage After Breakthrough Phase 2a Results
NTHI's position on Nasdaq gains new significance following the announcement of its breakthrough Phase 2a clinical trial results.
17 Aug, 12:45 — 17 Aug, 12:45
Sources
Showing 1 of 1 sources



